LDL Cholesterol, Direct (Measured) Test

The Direct LDL Cholesterol Test measures LDL cholesterol analytically rather than deriving it by calculation. LDL-C is the principal atherogenic lipid fraction and the central target of lipid-lowering therapy, so an accurate value is fundamental to cardiovascular risk assessment and treatment decisions. Within lipid assessment, the standard lipid panel calculates LDL-C, and for most patients that calculation is adequate. The direct assay earns its place where the calculation is unreliable: when triglycerides exceed roughly 400 mg/dL the Friedewald equation is invalid, and it also performs poorly at very low LDL-C and in non-fasting samples. In those situations a directly measured LDL-C gives a value the calculation cannot. It is worth noting, however, that direct LDL assays are not fully standardised between manufacturers and can themselves lose accuracy in marked hypertriglyceridaemia — so non-HDL cholesterol, which is simply total minus HDL and requires no assumptions, and ApoB, which counts atherogenic particles directly, remain important comparators and are often preferred in exactly these patients. Direct LDL-C is interpreted against risk-stratified targets alongside the wider lipid profile.